Erschienen in:

09.11.2020 | Correction

Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal

verfasst von: S. Batista, C. C. Nunes, J. J. Cerqueira, Ana Martins Silva, J. Correia de Sá, J. Ferreira, M. T. Mendonça, J. Pinheiro, V. Salgado, A. S. Correia, J. Sequeira, A. Costa, L. Sousa

Erschienen in: Neurological Sciences | Ausgabe 2/2021